(Q54391573)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Osteoprotegerin, a new actor in vasculogenesis, stimulates endothelial colony-forming cells properties (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

David M. Smadja

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Catherine Boisson-Vidal

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Ivan Bieche

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Sylvia Colliec-Jouault

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Z Benslimane-Ahmim

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

B Dizier

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A Lokajczyk

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

R Brion

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

I Laurendeau

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

I Galy-Fauroux

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

A M Fischer

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

1 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

Journal of Thrombosis and Haemostasis

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

834-843

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21255246%20AND%20SRC:MED&resulttype=core&format=json

Molecular regulation of angiogenesis and lymphangiogenesis

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Arteriogenesis versus angiogenesis: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Osteoprotegerin and RANKL differentially regulate angiogenesis and endothelial cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Breast cancer cells stimulate osteoprotegerin (OPG) production by endothelial cells through direct cell contact

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

RANKL/RANK/OPG: key therapeutic target in bone oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Inhibition of bone resorption, rather than direct cytotoxicity, mediates the anti-tumour actions of ibandronate and osteoprotegerin in a murine model of breast cancer bone metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Systemic osteoprotegerin gene therapy restores tumor-induced bone loss in a therapeutic model of breast cancer bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Serum osteoprotegerin levels and long-term prognosis in subjects with stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Relation of osteoprotegerin to coronary calcium and aortic plaque (from the Dallas Heart Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Clonal endothelial cells produce humoral factors that inhibit osteoclast-like cell formation in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Osteoprotegerin protects endothelial cells against apoptotic cell death induced by Porphyromonas gingivalis cysteine proteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Homing and engraftment of progenitor cells: a prerequisite for cell therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Endothelial colony-forming cell role in neoangiogenesis and tissue repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Low-molecular-weight fucoidan enhances the proangiogenic phenotype of endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

The angiopoietin pathway is modulated by PAR-1 activation on human endothelial progenitor cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Endothelial progenitor cells and their potential therapeutic applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Vascular endothelial growth factor up-regulates expression of receptor activator of NF-kappa B (RANK) in endothelial cells. Concomitant increase of angiogenic responses to RANK ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

The role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand in human microvascular endothelial cell survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Human endothelial progenitor cells tolerate oxidative stress due to intrinsically high expression of manganese superoxide dismutase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Osteoprotegerin upregulates endothelial cell adhesion molecule response to tumor necrosis factor-alpha associated with induction of angiopoietin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Pathophysiological roles of osteoprotegerin (OPG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Role of full-length osteoprotegerin in tumor cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

An imbalanced OPG/TRAIL ratio is associated to severe acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Osteoprotegerin Is an αvβ3-induced, NF-κB-dependent Survival Factor for Endothelial Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X

Contribution of bone marrow–derived endothelial cells to human tumor vasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2011.04207.X